Conformational regulation of two essential activators of bacterial cell elongation

M Morgan S. A. Gilman (Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School) I Irina Shlosman (Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School) D Daniel D. Samé Guerra (Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School) M Masy Domecillo E Elayne M. Fivenson (Department of Microbiology, Blavatnik Institute, Harvard Medical School) C Claire Bourett (Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School) T Thomas G. Bernhardt (Department of Microbiology) N Nicholas F. Polizzi J Joseph J. Loparo (Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School) A Andrew C. Kruse

Abstract

The peptidoglycan (PG) cell wall is critical for bacterial growth and survival and is a primary antibiotic target. MreD is an essential accessory factor of the Rod complex, which carries out PG synthesis during elongation, yet little is known about how MreD facilitates this process. Here, we present the cryoelectron microscopy structure of Thermus thermophilus MreD in complex with another essential Rod complex component, MreC. The structure reveals that a periplasmic-facing pocket of MreD interacts with multiple membrane-proximal regions of MreC. We use single-molecule FRET to show that MreD controls the conformation of MreC through these contacts, inducing a state primed for Rod complex activation. Using Escherichia coli as a model, we demonstrate that disrupting these interactions abolishes Rod complex activity in vivo. Our findings reveal the role of MreD in bacterial cell shape determination and highlight its potential as an antibiotic target.

Article Details

Volume / Issue Vol. 122, Issue 45
Published November 11, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

M

Morgan S. A. Gilman

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School

I

Irina Shlosman

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School

D

Daniel D. Samé Guerra

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School

M

Masy Domecillo

E

Elayne M. Fivenson

Department of Microbiology, Blavatnik Institute, Harvard Medical School

C

Claire Bourett

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School

T

Thomas G. Bernhardt

Department of Microbiology

N

Nicholas F. Polizzi

J

Joseph J. Loparo

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School

A

Andrew C. Kruse